The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer | MicrobiomeTrials← Back to trialsNCT04927416
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2021-10-25Est. Completion: 2030-11-30
Enrollment target: 54 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Advanced / Metastic Solid TumorsGlioblastomaChronic Leukemia Lymphocytic
The proposal is to conduct a prospective, multi-cohort study aiming to decipher molecular profiles/biological characteri…
Bron, FranceCompleted Sep 15, 2025